⚖UPC-Intel
🏛️ EPO Munich

EPO T 1417/24

Court
EPO Board of Appeal 3.3.07 (Munich)
Type of action
opposition appeal
Patent
LIQUID PHARMACEUTICAL FORMULATION
Language
en
Claimant / applicant
  • Project Pharmaceutics GmbH
Defendant / respondent
  • Oncopeptides AB

Track this case

Get an email when a new order or decision is published in EPO T 1417/24.

Decisions and documents (1)

Weekly digest

A weekly email summarising new published decisions across European patent courts.